HealthEquity Financials - Benzinga

HealthEquity Inc

HQYNASDAQ

Trade with Public

Trade with Public

$104.42

-0.97-0.92%

가까이에: Aug 26, 5:00 PM EST

$106.80

2.382.28%

시간외: 7:35 PM EST

실적: Q2 2027 실적이 내일 목 8월 27th에 개장 전 발표됩니다.

컨퍼런스 콜: 내일 8:30 AM에 컨퍼런스 콜이 예정되어 있습니다.

웹캐스트를 보려면 클릭하세요.

개요 뉴스 실적 전망 이벤트 목표가재무심리 지분 현황 비교 옵션 주식 보고서

HealthEquity Financials

HealthEquity (HQY) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
HealthEquity Raises FY2027 GAAP EPS Guidance from $2.78-$2.85 to $2.88-$2.95 vs $2.84 Est

Benzinga Newsdesk

PRO
HealthEquity Raises FY2027 Adj EPS Guidance from $4.56-$4.65 to $4.66-$4.73 vs $4.63 Est; Raises FY2027 Sales Guidance from $1.380B-$1.410B to $1.410B-$1.420B vs $1.411B Est

Benzinga Newsdesk

PRO
HealthEquity Q1 Adj. EPS $1.24 Beats $1.11 Estimate, Sales $354.641M Beat $351.862M Estimate

Benzinga Newsdesk

HealthEquity Analysts Cut Their Forecasts After Q4 Results

HealthEquity Inc (NASDAQ: HQY) beat earnings expectations for Q4, with adjusted EPS of 95 cents. FY2027 guidance raised and analysts maintain ratings.

Avi Kapoor

PRO
HealthEquity Sees FY2027 GAAP EPS $2.78-$2.85 vs $2.67 Est; Sees Sales $1.405B-$1.415B

Benzinga Newsdesk

PRO
HealthEquity Sees FY2027 Adj EPS $4.56-$4.65 vs $4.54 Est; Raises FY2027 Sales Guidance from $1.380B-$1.410B to $1.405B-$1.415B vs $1.410B Est

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved